2015 GI Cancers Symposium - Thursday
Read More
Eunice Lee Kwak, MD, PhD, Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, presenting "Abstract 1: Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer,"
San Francisco, CA - 2015 Gastrointestinal Cancers Symposium - San Francisco, CA: Eunice Lee Kwak, MD, PhD, Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, presenting "Abstract 1: Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer," during General Session 1: Drug Development, HER2 Pathway, And VEGF at the Gastrointestinal Cancers Symposium 2015 here today, Thursday January 15, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Thursday January 15, 2015. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154. GI15_DailyNews
